On August 23, 2017, Daniel R. Lapinski was appointed as a member of the Plaintiffs' Steering Committee in In re: Proton-Pump Inhibitor Products Liability Litigation, MDL No. 2789. The coordinated litigation is currently centralized before the Honorable Claire C. Cecchi, United States District Judge, in the United States District Court for the District of New Jersey. Proton-Pump Inhibitors (PPIs) are a class of medications commonly used to treat gastroesophageal reflux (GERD), dyspepsia , gastric ulcers and acid peptic disease. The more popular forms of PPIs include Prilosec, Prevacid, Nexium and AcipHex. Complaints against the manufacturers of these popular medications allege that the drugs are linked to an increased risk of chronic kidney disease and acute kidney injury.
If you or someone you know has experienced problems after having used proton-pump inhibitors, contact Mr. Lapinski at 732.855.6066 or email him at firstname.lastname@example.org.
Read the full Order Appointing Lead Counsel and Plaintiffs’ Steering Committee document, here.
The postings on this blog were created for general informational purposes only and do not constitute legal advice or a solicitation to provide legal services. Although we attempt to ensure that the postings are complete, accurate, and up to date, we assume no responsibility for their completeness, accuracy, or timeliness. The information in this blog is not intended to create, and receipt of it does not constitute, a lawyer-client relationship. Readers should not act upon this information without seeking professional legal counsel.
This blog may contain links to independent third party websites and services, including social media. We provide these links for your convenience, and you access them at your own risk. We have no control over and do not monitor the content or policies (including privacy policies) of these third-party websites and have no responsibility for, and no liability with respect to, their content, accuracy, or reliability. Unless expressly stated, we do not endorse any of the linked websites or any product, service, or publication referenced herein or therein. We will remove a link to any site from this blog upon request of the linked entity.
We grant permission to readers to link to this blog so long as this blog is not misrepresented. This site is not sponsored or associated with any other site unless so identified.
If you wish for Wilentz, Goldman & Spitzer, P.A., to consider representing you, please obtain contact information from the Contact Us area of this blog or go to the firm’s website at www.wilentz.com. One of our lawyers will be happy to discuss the possibility of representation with you. However, the authors of Wilentz blogs are licensed only in New Jersey and/or New York and do not wish to represent anyone who viewed this site in a state where the site fails to comply with all laws and ethical rules of that state.